On the livestock and poultry side, ARS is leading a major effort to use
genomics to improve the efficiency of animal production, especially in the area of feed utilization, to help reduce costs for producers and consumers, and to reduce the environmental impact of agriculture.
Attendees agreed on the need to ramp up the number of individuals with advanced
genomics training in the U.S.
The book is well-written and organized into three parts, with seven chapters in the introductory section that emphasize the scientific and social aspects of
genomics; five chapters on the role of
genomics in maternal, child, and adult health; and four chapters on areas of general interest.
Falcon
Genomics is a biotech company founded in August 2004.
On this launch, Gene Logic encouraged and called for partnerships with organizations and scientists working in areas like Diagnostics, Agro-Tech, Food and Neutraceuticals and other Discovery Areas saying that there is a huge scope of applying
genomics in R andD and for improving scientific support mechanisms in a consumers' perspective.
BMC
Genomics is an open access journal publishing original peer-reviewed research articles in all aspects of genome-scale analysis, functional
genomics, and proteomics.
Complete
Genomics, which is said to have reduced the cost of a genome sequence to approximately USD5000, will offer large-scale, affordable human genome sequencing services to pharmaceutical and biotechnology companies, as well as other medical researchers, which were previously priced out of the market.
Genomics is a newer term that describes the study of all the genes in a person, as well as interactions of those genes with each other and with that person's environment.
In June 2005, GNI merged with Shanghai
Genomics, which operates an integrated drug discovery platform, combining genetic discovery and drug development.
The incorporation of
genomics, proteomics, and bioinformatics adds a new dimension.
"We're pleased that Seattle Genetics has elected to move forward with this antigen," said Kathy Ordonez, president of Celera
Genomics. "With a strong combination of proprietary technology and practical experience, Seattle Genetics provides a promising opportunity for development of antibodies or ADCs based on our cancer targets."
The first phase of the collaboration will focus on applying IBM's Healthcare and Life Sciences Clinical
Genomics Solution to build the data infrastructure and interface for the over seven million records from the combined Utah databases.
